News Digest / Ticker: BVNRY

Ticker: BVNRY

07:43am, Friday, Sep 13, 2024

WHO Approves First Mpox Vaccine: What This Means for Bavarian Nordic and Biotech Investors

The WHO has approved Bavarian Nordic's mpox vaccine, a milestone for Africa amid outbreaks. With 13 million doses possible by 2025 and implications for biotech stocks, traders should monitor its impact on public health and market sentiment.